
Pharma CEOs Face Scrutiny Over Drug Prices in Senate Hearing
Published on February 8, 2024
A Senate committee hearing on the price of prescription drugs turned into a disagreement on the value of capitalism in the field of medicine and drug development. Drug company CEOs were in the hot seat during the Feb. 8 hearing, as Sen. Bernie Sanders (I-Vt.) attempted to pin down the reason for high drug costs and obtain commitments to lower the cost of the medications. In the course of a hearing held by the Senate Health, Education, Labor, and Pensions Committee, Mr. Sanders questioned the chief executive officers of Merck, Johnson & Johnson, and Bristol Myers Squibb regarding the reasons for the much higher prices of their pharmaceuticals in the United States in comparison with other countries....
